ESC Premium Access

Hot Line - FIGARO-DKD / FIDELITY Analysis

Event: ESC Congress 2021 - The Digital Experience
Topic: Pharmacology and Pharmacotherapy
Session type: Hot Line
Date: 28 August 2021
Time: 17:25 - 18:10

Session

Become an ESC member to access this resource

Become a member

Already a member? Sign in

6 presentations in this session

FIGARO-DKD: finerenone in patients with chronic kidney disease and type 2 diabetes

Speaker: Professor B. Pitt (Ann Arbor, US)
Thumbnail

FIGARO-DKD - Discussant review.

Speaker: Doctor K. Damman (Groningen, NL)
Thumbnail

FIDELITY Analysis: finerenone in mild-to-severe chronic kidney disease and type 2 diabetes - Part 1

Thumbnail

FIDELITY Analysis: finerenone in mild-to-severe chronic kidney disease and type 2 diabetes

Speaker: Professor G. Filippatos (Athens, GR)
Thumbnail

FIDELITY Analysis - Discussant review.

Speaker: Professor C. Baigent (Oxford, GB)
Thumbnail

FIGARO-DKD / FIDELITY Analysis - Panel discussion.

Thumbnail

4 speakers from this session

Professor Bertram Pitt

University of Michigan, Ann Arbor (United States of America)
19 presentations
0 follower

Doctor Kevin Damman

University Medical Center Groningen, Groningen (Netherlands (The))
10 presentations
1 follower

Professor Gerasimos Filippatos

National & Kapodistrian University of Athens Medical School, Athens (Greece)
53 presentations
1 follower

Professor Colin Baigent

University of Oxford, Oxford (United Kingdom of Great Britain & Northern Ireland)
10 presentations
0 follower

Related content

ESC Premium Access

Current controversies in antithrombotic therapy

3 December 2021

This platform is supported by

logo Novo Nordisk